CDT Equity CDT
NASDAQ CDT
$0.40 -0.04 (-9.09%)
At close: Nov 13, 2026 · 4:00 PM EST

CDT Equity (CDT) Capital Expenditures (2024 - 2025)

Updated

CDT Equity's Capital Expenditures was -$7,000 in Q3 2025, compared with $41,000 a year earlier.

Analysis

CDT Equity (CDT) Capital Expenditures (2024 - 2025) Analysis & Trends

On a trailing twelve-month basis, CDT Equity's Capital Expenditures was $398,000 through Sep 30, 2025; for FY2024, it was $51,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 1.36 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 301.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 237.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 573.00 Mn
10 CDT Equity 426.40 -6.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -7,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 404,000.00
Sep 30, 2024 41,000.00
API Access

CDT Equity Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CDT&period=max&api_key=YOUR_API_KEY